Quick Answer
P3 Health Partners Inc. reported Cash And Cash Equivalents At Carrying Value of $25.01 million for the year ending 2025.
- P3 Health Partners Inc. showed a decrease of -35.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from P3 Health Partners Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2019 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $22.34 million | Q2 2021: $16.32 million | Q3 2021: $4.34 million | Q1 2022: $110.35 million | Q2 2022: $63.15 million | Q3 2022: $34.36 million | Q1 2023: $7.18 million | Q2 2023: $59.92 million | Q3 2023: $52.56 million | Q1 2024: $27.30 million | Q2 2024: $73.09 million | Q3 2024: $62.96 million | Q1 2025: $40.08 million | Q2 2025: $38.58 million | Q3 2025: $37.71 million.
- Over the full 8 years of available data (2019 to 2025), P3 Health Partners Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 23.3%.
- Historical annual values: Fiscal year 2025: $25.01 million | Fiscal year 2024: $38.82 million | Fiscal year 2023: $36.32 million | Fiscal year 2022: $17.54 million | Fiscal year 2021: $140.48 million | Fiscal year 2021: $5.30 million | Fiscal year 2020: $36.26 million | Fiscal year 2019: $32.59 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: